Nam-On Ku Selected Research

K-18 conjugate (K18)

1/2019	Keratins regulate Hsp70-mediated nuclear localization of p38 mitogen-activated protein kinase.
1/2019	Liver disease-associated keratin 8 and 18 mutations modulate keratin acetylation and methylation.
1/2016	Keratins: Biomarkers and modulators of apoptotic and necrotic cell death in the liver.
5/2012	Keratins: markers and modulators of liver disease.
9/2010	Cytoskeletal keratin glycosylation protects epithelial tissue from injury.
7/2009	Toward unraveling the complexity of simple epithelial keratins in human disease.
11/2007	Keratins let liver live: Mutations predispose to liver disease and crosslinking generates Mallory-Denk bodies.
5/2006	Denaturing temperature selection may underestimate keratin mutation detection by DHPLC.
5/2003	Keratin 8 and 18 mutations are risk factors for developing liver disease of multiple etiologies.
5/2003	Keratin mutation in transgenic mice predisposes to Fas but not TNF-induced apoptosis and massive liver injury.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Nam-On Ku Research Topics

Disease

14	Liver Diseases (Liver Disease) 01/2019 - 05/2003
5	Fibrosis (Cirrhosis) 01/2021 - 05/2003
3	Necrosis 01/2016 - 05/2012
3	End Stage Liver Disease 11/2007 - 09/2005
2	Hepatocellular Carcinoma (Hepatoma) 06/2021 - 05/2012
2	Non-alcoholic Fatty Liver Disease 01/2016 - 05/2012
2	Neoplasms (Cancer) 01/2016 - 05/2012
2	Virus Diseases (Viral Diseases) 01/2016 - 09/2005
2	Infections 11/2007 - 08/2004
1	Inflammation (Inflammations) 01/2021
1	Acute Lung Injury 01/2021
1	Lung Injury 01/2021
1	Hemorrhage 01/2021
1	Acute Liver Failure (Fulminant Hepatic Failure) 01/2016
1	Lung Diseases (Lung Disease) 07/2013
1	Disease Progression 11/2007
1	Chronic Hepatitis C 11/2007
1	Chronic Pancreatitis 05/2006
1	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 05/2006
1	Cryptogenic Cirrhosis 05/2003
1	Liver Cirrhosis (Hepatic Cirrhosis) 05/2003
1	Chemical and Drug Induced Liver Injury 05/2003
1	Chronic Hepatitis (Chronic Active Hepatitis) 05/2003
1	Epidermolytic Hyperkeratosis (Bullous Congenital Ichthyosiform Erythroderma) 03/2002

Drug/Important Bio-Agent (IBA)

14	Keratins (Keratin)IBA 01/2019 - 03/2002
10	K-18 conjugate (K18)IBA 01/2019 - 05/2003
6	Keratin-8 (Keratin 8)IBA 06/2021 - 05/2003
3	Proteins (Proteins, Gene)FDA Link 06/2021 - 05/2003
2	Keratin-18 (Keratin 18)IBA 01/2019 - 04/2014
2	AntibodiesIBA 01/2016 - 08/2004
2	EpitopesIBA 01/2016 - 02/2006
2	CaspasesIBA 01/2016 - 04/2014
2	DNA (Deoxyribonucleic Acid)IBA 05/2006 - 05/2003
2	Phosphotransferases (Kinase)IBA 08/2004 - 03/2002
1	Arginine (L-Arginine)FDA Link 01/2021
1	Bleomycin (Blenoxane)FDA LinkGeneric 01/2021
1	Intermediate Filament ProteinsIBA 01/2019
1	p38 Mitogen-Activated Protein KinasesIBA 01/2019
1	ImmunosorbentsIBA 01/2016
1	EnzymesIBA 01/2016
1	Biomarkers (Surrogate Marker)IBA 01/2016
1	Tissue Polypeptide AntigenIBA 01/2016
1	tissue polypeptide specific antigenIBA 01/2016
1	VimentinIBA 07/2013
1	Protein Glutamine gamma Glutamyltransferase 2IBA 05/2012
1	Amino Acids FDA Link 05/2006
1	Okadaic AcidIBA 03/2002